Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Spinal interneurons and motor neurons" describes two related but distinct cell types within the spinal cord. Spinal interneurons are neurons within the spinal cord that mediate communication between sensory inputs and motor outputs, playing central roles in reflex modulation, sensorimotor integration, and circuit formation. They are diverse, comprising both inhibitory (GABAergic, glycinergic) and excitatory (glutamatergic) subtypes, and are crucial for the coordination and modulation of muscular movement and spinal reflexes. Their activity is critical for movement efficiency and coordination, and dysfunction can contribute to neurological disease. Spinal motor neurons are efferent neurons in the spinal cord responsible for initiating and controlling muscle contraction by transmitting signals from the central nervous system to skeletal muscles. They are organized into functional pools or columns, each innervating specific muscle groups, and their degeneration is central to diseases like amyotrophic lateral sclerosis (ALS). They use acetylcholine as their primary neurotransmitter at the neuromuscular junction. These are not a single molecule, receptor, or protein, nor are they molecular therapeutic targets in the usual pharmacological sense. They represent functional classes of neurons, not a defined targetable molecule, receptor, or gene. Proper scientific terminology would require specificity, such as "GABA_A receptor on spinal interneurons" or "alpha motor neuron cholinergic receptor."
For drugs affecting these neurons: - Enhancement of inhibitory neurotransmission (GABAergic, glycinergic) - Modulation of glutamatergic signaling - Indirect modulation via higher CNS centers
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spinal Interneurons and Spinal Motor Neurons (SI, SMN).